9-(Dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole

Catalog No. :
ACNYDQ156
CAS No. :
1345143-35-2
Molecular Formula :
C30H26BNO2S
Molecular Weight :
475.42

IUPAC Name:9-(dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole

9-(Dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-(Dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
IUPAC Name9-(dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole
Molecular FormulaC30H26BNO2S
Molecular Weight475.42
SMILESCC1(C)C(C)(C)OB(C2=CC3=C(C=C2)N(C4=C5C(C6=CC=CC=C6S5)=CC=C4)C7=C3C=CC=C7)O1
InChI KeyAPKQBXVZWGJJIQ-UHFFFAOYSA-N
Synonym9-Dibenzothiophen-4-yl-3-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-9H-carbazole;9-(dibenzo[b,d]thiophen-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole;9H-Carbazole, 9-(4-dibenzothienyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1345143-35-2

Synthetic Route by SureRoute

1. ACNYDQ156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACNYDQ156 route product structure diagram
    ACNYDQ1561345143-35-2
Inquiry

2. ACNYDQ156 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWYQV536 route compound structure diagram
    ACWYQV53697511-05-2 In Stock
  2. Plus
  3. ACMHXE401 route compound structure diagram
    ACMHXE401855738-89-5 In Stock
  4. Then
  5. ACNYDQ156 route product structure diagram
    ACNYDQ1561345143-35-2
Inquiry

Comments (0)